SAB Biotherapeutics, Inc.
SABS
$3.70
-$0.05-1.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,696.28% | 735.71% | 365.27% | 264.73% | -84.69% |
| Total Receivables | -- | 7,166.82% | 1,621.45% | 477.32% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.72% | 11.98% | 18.03% | -9.96% | 77.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1,059.60% | 592.05% | 324.73% | 248.15% | -76.48% |
|
|
|||||
| Total Current Assets | 1,059.60% | 592.05% | 324.73% | 248.15% | -76.48% |
| Net Property, Plant & Equipment | -4.02% | -5.62% | -2.59% | -6.30% | -6.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,180.00% | 1,073.79% | 1,032.44% | -75.87% | -19.97% |
| Total Assets | 690.62% | 551.81% | 291.01% | 241.00% | -51.32% |
|
|
|||||
| Total Accounts Payable | 47.00% | 40.65% | 85.63% | 127.83% | 123.89% |
| Total Accrued Expenses | 1.65% | -11.05% | 20.30% | -0.43% | 40.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -33.45% | -14.53% | 17.20% | 88.36% | -20.51% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.63% | 2.06% | 33.86% | 22.43% | 41.38% |
|
|
|||||
| Total Current Liabilities | 9.63% | 2.06% | 33.86% | 22.43% | 41.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.68% | -7.94% | 29.61% | 30.12% | 32.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 265.01% | 351.98% | -11.80% | -41.67% | -51.57% |
| Total Liabilities | 29.32% | 26.98% | 16.95% | 8.76% | 14.84% |
|
|
|||||
| Common Stock & APIC | 137.84% | 131.93% | 71.84% | 70.52% | 1.91% |
| Retained Earnings | -9.16% | -0.31% | 10.69% | 16.62% | -36.18% |
| Treasury Stock & Other | -16.51% | -1.97% | 5.69% | 0.35% | 0.28% |
| Total Common Equity | 1,687.46% | 961.54% | 483.35% | 347.32% | -73.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,687.46% | 961.54% | 483.35% | 347.32% | -73.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,687.46% | 961.54% | 483.35% | 347.32% | -73.95% |
|
|
|||||